Cargando…
Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers
INTRODUCTION: Ingenol mebutate gel (Picato(®), LEO Pharma A/S) is approved for the field treatment of actinic keratosis and is characterized by high sustained clearance of actinic lesions. The inherent propensity of ingenol mebutate towards chemical rearrangement necessitates refrigeration of the fi...
Autores principales: | Bertelsen, Malene, Stahlhut, Martin, Grue-Sørensen, Gunnar, Liang, Xifu, Christensen, Gitte Bach, Skak, Kresten, Engell, Karen Margrethe, Högberg, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120626/ https://www.ncbi.nlm.nih.gov/pubmed/27503482 http://dx.doi.org/10.1007/s13555-016-0137-2 |
Ejemplares similares
-
Ingenol mebutate: A novel topical drug for actinic keratosis
por: Aditya, Suruchi, et al.
Publicado: (2013) -
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
por: Berman, Brian
Publicado: (2012) -
Ingenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients
por: Joe, Hyun Jae, et al.
Publicado: (2017) -
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
por: Campione, Elena, et al.
Publicado: (2016) -
Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp
por: Skroza, Nevena, et al.
Publicado: (2017)